代谢综合征合并脑卒中67例分析

目的探讨代谢综合征(MS)合并脑卒中的临床特点及预后。方法对经头颅CT或MRI证实的脑卒中合并MS67例和同期住院脑卒中非MS105例的临床资料(包括卒中类型、预后、并发症)进行分析比较。结果脑梗塞MS组92.53%,非MS组85.71%;近期死亡率MS组25.37%,非MS组8.57%;住院期间并发症,MS组肺部感染、呼吸衰竭、心力衰竭、肾功能衰竭机率较非MS组明显升高,脑疝和消化道出血两组差异无显著性。结论代谢综合征合并脑卒中以脑梗塞多见,住院期间并发症多,近期死亡率高。

Objective To investigate the clinical characteristics of stroke with metabolic syndrome and analysis their prognosis. Methods 67 stroke patients with metabolic syndrome were recruited, and 105 stroke patients without metabolic syndrome as controls. Results The prevalence of cerebral infarction was significantly increasing in stroke patients in MS group than those in control group. The prognosis of patients in control group 25.37% ） were better than the stroke patients in MS group （mortabty = 8.57% ）. There was significant difference in severe complication, including puhnonary infection, respiratory, failure, heart failure, arrythmias and kidney failure between MS group and control group（ p 〈 0.05）. However, there was no significant difference in onset of cerebral hernia and gastrointestinal hemorrhage between the two groups. Conclusion The prevalence of cerebral infarction remarkably increased in stroke patients with metabolic syndrome. The mortality and incidence of complication in stroke with metabolic syndrome is higher.